Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Sagent Pharmaceuticals acquires Omega Laboratories

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Omega Laboratories Ltd.

On October 1st, 2014, Omega Laboratories announced its sale to Sagent Pharmaceuticals as part of a $95 million transaction. With this transaction, Omega Laboratories joins Sageant Pharmaceuticals’ multinational team while maintaining its foundation and jobs in the province of Quebec, and is now in a position to deploy its international expansion plans and strategies earlier than expected. Based in Montreal, Omega Laboratories offers a full range of innovative and specialized products and services to the pharmaceutical industry. Among other things, it manufactures a broad range of injectable and non-injectable solutions. Sagent Pharmaceuticals is an Illinois-based pharmaceutical company. Fasken Martineau acted as counsel to Omega Laboratories with a team led by Patrice Vachon and including Marie-Eve Clavet, Kiran Singh, Anabel Quessy, Joëlle Simard, Pierre-Olivier Charlebois, Emilie Bundock and Alain Ranger.

Team

    Subscribe

    Receive email updates from our team

    Subscribe